Screener
Relmada Therapeutics, Inc. RLMD Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055059
| Line item | As of / March 31, | As of |
|---|---|---|
| Stockholders’ Equity: | ||
| Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding | - | - |
| Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding | - | - |
| Common stock, $0.001 par value, 150,000,000 shares authorized, 104,890,223 and 73,333,622 shares issued and outstanding, respectively | 104,890 | 73,333 |
| Additional paid-in capital | 935,946,841 | 784,705,878 |
| Accumulated deficit | (717,319,154) | (698,267,198) |
| Total stockholders’ equity | 218,732,577 | 86,512,013 |
| Total liabilities and stockholders’ equity | $235,362,794 | $94,003,471 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share)?
- Relmada Therapeutics, Inc. (RLMD) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude